221 related articles for article (PubMed ID: 18723208)
21. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
22. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
Secin FP; Bianco FJ; Vickers AJ; Reuter V; Wheeler T; Fearn PA; Eastham JA; Scardino PT
Cancer; 2006 Jun; 106(11):2369-75. PubMed ID: 16649221
[TBL] [Abstract][Full Text] [Related]
23. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?
Pfitzenmaier J; Pahernik S; Tremmel T; Haferkamp A; Buse S; Hohenfellner M
BJU Int; 2008 Nov; 102(10):1413-8. PubMed ID: 18537951
[TBL] [Abstract][Full Text] [Related]
24. Pathologic T2 stage subgroups and recurrence-free survival after radical prostatectomy.
DeCastro GJ; McCann T; Benson MC; McKiernan JM
Urology; 2008 Dec; 72(6):1214-8. PubMed ID: 18597825
[TBL] [Abstract][Full Text] [Related]
25. Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients.
Baccala A; Reuther AM; Bianco FJ; Scardino PT; Kattan MW; Klein EA
Urology; 2007 Mar; 69(3):536-40. PubMed ID: 17382160
[TBL] [Abstract][Full Text] [Related]
26. Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy.
Guzzo TJ; Vira MA; Neway W; Hwang WT; Tomaszewski J; VanArsdalen K; Wein AJ; Malkowicz SB
Urology; 2007 Jun; 69(6):1147-51. PubMed ID: 17572204
[TBL] [Abstract][Full Text] [Related]
27. Independent prognostic importance of microvessel density in clinically localized prostate cancer.
Halvorsen OJ; Haukaas S; Høisaeter PA; Akslen LA
Anticancer Res; 2000; 20(5C):3791-9. PubMed ID: 11268456
[TBL] [Abstract][Full Text] [Related]
28. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival.
Tollefson MK; Leibovich BC; Slezak JM; Zincke H; Blute ML
J Urol; 2006 Feb; 175(2):547-51. PubMed ID: 16406993
[TBL] [Abstract][Full Text] [Related]
29. An analysis of risk factors for biochemical progression in patients with seminal vesicle invasion: validation of Kattan's nomogram in a pathological subgroup.
Ramsden AR; Chodak G
BJU Int; 2004 May; 93(7):961-4. PubMed ID: 15142143
[TBL] [Abstract][Full Text] [Related]
30. Predictive significance of surgical margin status after prostatectomy for prostate cancer during PSA era.
Mann MJ; DeCastro GJ; Desai M; Benson MC; McKiernan JM
Urology; 2008 Dec; 72(6):1203-7. PubMed ID: 18674807
[TBL] [Abstract][Full Text] [Related]
31. Does year of radical prostatectomy independently predict outcome in prostate cancer?
Mitchell RE; Shah JB; Olsson CA; Benson MC; McKiernan JM
Urology; 2006 Feb; 67(2):368-72. PubMed ID: 16461087
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy.
Hashimoto K; Masumori N; Takei F; Fukuta F; Takahashi A; Itoh N; Hasegawa T; Tsukamoto T
Jpn J Clin Oncol; 2008 Jan; 38(1):31-5. PubMed ID: 18203710
[TBL] [Abstract][Full Text] [Related]
33. Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrence.
Marks RA; Lin H; Koch MO; Cheng L
Am J Surg Pathol; 2007 Jun; 31(6):877-81. PubMed ID: 17527074
[TBL] [Abstract][Full Text] [Related]
34. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
Xylinas E; Drouin SJ; Comperat E; Vaessen C; Renard-Penna R; Misrai V; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Roupret M
BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
[TBL] [Abstract][Full Text] [Related]
35. Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
Nielsen ME; Makarov DV; Humphreys E; Mangold L; Partin AW; Walsh PC
Urology; 2008 Aug; 72(2):389-93; discussion 394-5. PubMed ID: 18279937
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens.
May M; Kaufmann O; Hammermann F; Loy V; Siegsmund M
BJU Int; 2007 Mar; 99(3):539-44. PubMed ID: 17155973
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy.
May M; Siegsmund M; Hammermann F; Loy V; Gunia S
Scand J Urol Nephrol; 2007; 41(5):375-81. PubMed ID: 17853019
[TBL] [Abstract][Full Text] [Related]
38. Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy.
Jeon HG; Bae J; Yi JS; Hwang IS; Lee SE; Lee E
Int J Urol; 2009 Aug; 16(8):682-6. PubMed ID: 19602004
[TBL] [Abstract][Full Text] [Related]
39. [Seminal vesicle invasion afer radical prostatectomy: study of risk factors for progression].
Salomon L; Levrel O; de la Taille A; Hoznek A; Chopin D; Abbou CC
Prog Urol; 2002 Sep; 12(4):621-7. PubMed ID: 12463121
[TBL] [Abstract][Full Text] [Related]
40. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
